Jhep Reports : Innovation in Hepatology
Overview
Jhep Reports : Innovation in Hepatology is a scientific journal, published since 2019 in English. The journal's country of origin is Netherlands and its primary focus area is gastroenterology.
Details
Details
Abbr.
JHEP Rep
Start
2019
End
Continuing
e-ISSN
2589-5559
Country
Netherlands
Language
English
Specialty
Gastroenterology
Metrics
Metrics
h-index / Ranks: 8422
42
SJR / Ranks: 475
3409
CiteScore / Ranks: 884
12.40
Recent Articles
1.
Igarashi Y, Akiyama Y, Shimada S, Watanabe S, Hatano M, Kodera K, et al.
JHEP Rep
. 2025 Mar;
7(3):101307.
PMID: 40059971
Background & Aims: The inhibition of epigenetic regulators activates endogenous retrovirus (ERV) expression, which can stimulate a viral mimicry response in cancer cells. ERV elements are aberrantly expressed in hepatocellular...
2.
Gairing S, Mildenberger P, Gile J, Artusa F, Scheiner B, Leyh C, et al.
JHEP Rep
. 2025 Mar;
7(3):101295.
PMID: 40059970
Background & Aims: Immunotherapy with atezolizumab and bevacizumab (a + b) has improved the prognosis of patients with unresectable hepatocellular carcinoma (HCC). However, the outcome for individual patients is highly...
3.
4.
Houttu V, Boulund U, Troelstra M, Csader S, Stols-Goncalves D, Mak A, et al.
JHEP Rep
. 2025 Mar;
7(3):101289.
PMID: 40051412
Background & Aims: Exercise is a key component of lifestyle management in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), but neither its therapeutic effect on the active stage of...
5.
Anolli M, Uceda Renteria S, Degasperi E, Facchetti F, Sambarino D, Borghi M, et al.
JHEP Rep
. 2025 Mar;
7(3):101299.
PMID: 40051411
Background & Aims: Accurate HDV RNA quantification is crucial for diagnosis and management of chronic hepatitis delta (CHD), yet a significant variability between assays exists. We compared three methods to...
6.
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence
Burra P, Battistella S, Turco L, Morelli M, Frassanito G, De Maria N, et al.
JHEP Rep
. 2025 Mar;
7(3):101278.
PMID: 40041120
Background & Aims: Conflicting data exist regarding optimal prophylaxis for HBV recurrence (HBV-R) after liver transplantation (LT), particularly in patients with hepatocellular carcinoma (HCC). We assessed current practices for HBV-R...
7.
Li Z, Ma L, Chen M, Chen X, Sha M, Hang H
JHEP Rep
. 2025 Mar;
7(3):101275.
PMID: 40041119
Background & Aims: Lymph node metastasis (LNM) is a major determinant of recurrence and prognosis in intrahepatic cholangiocarcinoma (iCCA). LNM disrupts T cell-mediated cytotoxicity, promotes tumor-specific immune tolerance, and facilitates...
8.
Shalaby S, Battistel M, Groff S, Birbin L, Miraglia R, Angeli P, et al.
JHEP Rep
. 2025 Mar;
7(3):101301.
PMID: 40041118
Background & Aims: There is a lack of consensus on the optimal management of fundal gastric varices (GVs) in patients with cirrhosis due to varied anatomy and hemodynamics. In this...
9.
Leung K, Li W, Hansen B, Gulamhusein A, Lapointe-Shaw L, Shaheen A, et al.
JHEP Rep
. 2025 Mar;
7(3):101272.
PMID: 40041117
Background & Aims: Primary sclerosing cholangitis (PSC) carries significant morbidity and mortality compared with inflammatory bowel disease (IBD). We characterized epidemiology trends and outcomes in those with PSC-IBD and IBD,...
10.
Mandorfer M, Abraldes J, Berzigotti A
JHEP Rep
. 2025 Mar;
7(3):101300.
PMID: 40034396
Portal hypertension (PH) leads to life-threatening clinical manifestations such as bleeding from gastro-oesophageal varices, ascites and its complications, and portosystemic encephalopathy. It can develop because of advanced chronic liver disease...